Leo’s Congenital Ichthyosis Candidate Fails Phase III Study

Drug Acquired In Timber Purchase

 
• By Joseph Haas

TMB-001, a topical formulation of isotretinoin, missed its primary endpoint in the ASCEND study and will not be filed for approval. Leo is turning its attention to hand eczema and dealmaking.

topical medication
Leo hoped to develop a topical as the first drug therapy for congenital ichthyosis • Source: Shutterstock

More from Clinical Trials

More from R&D